Home | Log In | Register | Our Services | My Account | Contact | Help |
Premarket Futures 20th Oct | FTSE +- | DAX +- | DOW +- | S&P +- | Nasdaq +- |
|
FTSE 250 |
FTSE Small Cap |
FTSE TechMark |
|
Nasdaq 100 |
S&P 500 |
S&P Futures |
|
|
10 Year Bond |
![]() |
News: | Sorry Your browser is not java capable | |
US Close:
The news will be posted approx 7:35 in the morning |
|
|
|
![]() |
|
|
|
![]() |
Trading Thoughts & Week Ahead -- Sunday 19th Oct |
Monday Sage the last remaining FTSE tech stock said in April 11 first-half results were in line with expectations. Analysts expect Sage to increase its dividends buy at least 7% this year in the year ahead. Legal and General On Friday UBS reiterated its buy on while trimming the target price to 115p from 118p. Tuesday Allied Domecq could signal its intention to acquire an alternative Australian wine producer after its unsuccessful attempt to buy Australian company Peter Lehmann Wines. Profits are likely to be unchanged at 480m for the year with sales increases in its quick service restaurants and wine sales offset by higher pensions costs, weakness of the US dollar and inventory de-stocking. ARM Holdings are expected to say that revenues are flat and produce profits of 5.5m against 6.5m in the previous three months Lower royalty income because of deflation and a build up in inventories in Asia is likely to have affected turnover. Investors will be keen to hear the company's thoughts on the prospect of a rebound in 2004. CBI's industrial trends survey will offer clues on the pace of economic revival WednesdayGlaxoSmithKline will provide investors with a chance to gauge the impact of generic competition following the launch of a copycat version of its blockbuster anti-depressant Paxil. Despite the competition sales are likely to show growth in the high single digits and profits are expected to rise to around 1.7bn from 1.4bn. In July, Glaxo launched two new products in the US, Levitra and Webutrin. Reuters is trying to offset falling sales by costs cutting. In July it expected full-year revenues to decline around 11%, though it stressed that its "Fast Forward" rationalisation programme was progressing well, achieving cost savings ahead of plan.Bad Egg? Q3 figures are expected to have been hit by its costly attempt to crack the credit card business in France which has failed and it may have withdraw from the French market. Predicting the company's performance is a difficult task and analysts forecasts vary by as much as 52m. There is also a rumour that the Prudential intends to sell its 79 percent stake in Egg. (Keep an eye on Prudential!) The minutes from the Bank of England's last meeting will show if the mood is shifting towards a raise in interest rates. House builder stocks could react to the news. ThursdayShell is expected to report strong Q3 earnings with growth up to 1.87bn from 1.34bn a year earlier. Higher oil and gas prices following the Iraq conflict will be partly offset by the hot summer weather in EuropeAstraZeneca, which reports Q3 figures has also been hit by generic competition to its ulcer drug Prilosec. But it has also been busy getting drugs to the market with its cholesterol treatment Crestor in the US and recently said 14 European countries have extended the use of Seroquel to treat manic-depressive illness. Sales are expected to have grown by around 10% but anaysts expect profits to have slipped to 511m from 538m. However In July, AstraZeneca was upbeat about is full-year prospects and lifted its profit estimates by 6%. Amvescap: On Friday Dresdner Kleinwort Wasserstein upgraded it to reduce from sell, with a 470p price target FridayAutonomy release Q3 results and said at the start of the month that earnings for the last quarter should be ahead of market estimates. WPP said in August that it reckoned the advertising industry was starting to climb out of the bathtub of recession. Well lets hope they haven't slipped on the soap. Third quarter GDP data will show if the UK's economic revival is still on track Thoughts As expected last week the market optimism lifted the FTSE 100 some 80 points to a 14-month high of 4,383 points on Wednesday before it lost some ground falling to 4,344 on Friday, up 0.6 percent on the week and more than 6 percent already this month. In the U.S. Q3 earnings increased the confidence that the 3 year slump is finally over with improving economic data being reflected in company profits. Technology stocks rose as companies reported that spending on IT and software is increasing. But there is usually a BUT or HOWEVER and this week is no exception with a feeling that the rally may have gone too far and too fast. This nervousness may result in a fall back next week especially as it is the anniversary of the 1987 stock market crash when the FTSE 100 tumbled 22 percent in two days. Looking at the chart we have a trend trading range of 4310/4410 for the week ahead which can be extended forward to 4440/4540 by Xmas if there is not a change in sentiment. With the current FTSE at 4344 we have more upside potential than down but I would not be surprised to see a test of support mid week. As always I look forward to your thoughts and comments on the week ahead! David (Crocodile) David@FTSEDOW.COM www.FTSEDOW.comAll the above comments are purely a personal opinion and no investment advice is intended. Please do your own research. |
Sunday News |
Headlines 19th October Superstores To Face Christmas Day Ban - Sky News - Government faces huge debt deficit - Britain faces a current account deficit of over twice Chancellor Gordon Brown's budget forecast and a net borrowing requirement of around 10 billion pounds above his 27 billion forecast for the 2003 financial year, according to a survey. Reuters. Shareholders reportedly want to oust ITV Carlton Communications and Granada, boss - Reuters Equitable Exes Lose Fight - Nine former non-executive directors of Equitable Life have failed to block a multi-million pound lawsuit launched against them by the troubled mutual insurer.The legal action was launched in the wake of the financial disaster which brought it close to collapse three years ago. SKY |
|
SUNDAY TIMES Unilever and Kerry bid for PJ Smoothies Dixons Business Digest Alizyme boss finds a cure for the stock market blues Alizyme Green has two days to save himself Ex-boss missed out on First Active share jackpot Arcadia Group I can manage as well as buy Barclays Barrett to get 500,000 for a three-day week Irish Business Digest Independent News and Media Revealed: Monsoons rebel shareholder Consortium plans 103m Gresham bid Cable and Wireless Bank in cheap calls connection Randgold to raise its Ashanti bid Scottish and Newcastle Price rises leave publicans crying in their beer Royal Bank of Scotland Bank in cheap calls connection Sharewatch: Anglo Irish Bank Capita Group |
Granada Focus: Coup at ITV Judgment Day: Should you buy shares in Matalan? Dixons Scottish Business Digest EMI, Granada, Carlton The truth will out no matter what Fidelity says Vital Statistics Cattles Holdings Sharewatch: Paddy Power Antisoma Drugs firms help Footsie to climb further Barclays What made me do a Ratner? Cattles Holdings Cattles boss takes a creditable line HBOS Value rolls on up Carlton Coup at ITV Cattles Holdings Sean Mahon's working day Sharewatch: Minmet JJB Sports Directors' Deals: Sportswear boss nets a 10m profit Working Space |
SUNDAY TELEGRAPH Granada, Carlton Tuesday deadline for Michael Green to quit ITV Balfour Beatty Network Rail plans to take back all maintenance work Shell to build $5bn 'clean fuel' plant in Qatar Arcadia Group Philip Green pays back 500m debt to HBOS |
Barclays Barrett reaches his credit limit Mitchells & Butlers Carr: It's Spirit's funeral Canary Wharf Reichmann faces pressure to quit BSkyB investors turn up heat on Murdoch over job for son |
Shares in advertising giant WPP have risen 25% to 570 1/2p this year, although there should be further to go as the group's target of a market upturn in 2004 nears. Third quarter results next month should also boost the price. Pharmaceuticals group GlaxoSmithKline is due to update investors on its drugs pipeline in December, so analysts are expecting an uplift in anticipation of some positive news. Shares are a buy at 1282p. High-speed telecommunications provider Fibernet last week announced sharply reduced losses and a surge in new contracts. With analysts looking for the company to move into the black in 2006, Fibernet is a buy at 96 1/2p. Sondex, a company which makes equipment to monitor oil and gas fields, has been a solid performer since joining the market in June. It is due to open an office in the UAE, while revenues growth rates have increased. Buy at 133 1/2p. Shares in specialist mortgage lender Paragon should have further to go despite more than doubling in the last year to 361p. The group, which concentrates on the buy-to-let market, should benefit from growth in the rented sector. Eckoh, the speech application group, should net at least 100,000 from a deal with BT and TD Waterhouse to provide share prices to more than 1,000 customers. Further growth could come from a recent acquisition. Buy at 15 1/4p. | |
OBSERVER Carlton, Granada ITV boards to resist City rebels BT Group Eurocreep infiltrates the United Kingdom Egg beaten by the French Randgold set to table counter-bid for Ashanti Trinity Mirror of gloom as Sly rescue plan stalls London Stock Exchange Not so fast to the altar, LSE |
Black cloud over BP oil deal Carlton Is Fidelity tuning up an American ITV? Barclays Trouble on the cards BP, Lloyds, RBOS, Bear market over? That's just a load of bull Barclays Will the gaffer decide to go? |
SUNDAY MAIL Treasury 5bn raid on miners' pensions Break-up on cards for Kingston Cost-cutting drive at phone group Vodafone back in the spotlight Barclays hit by customer backlash, Credit card anger swamps phone lines Green tipped for 200m-plus profits, Strong results due from Bhs, Arcardia Connex faces a fast-track exit, Rail firm may be forced out early |
Mortgage misery 'within 18 months', Runaway credit prompts 5% rates fear 2.5bn Laurel pubs sale looming, Deutsche Bank looking for way out Suitors hover for Chelsfield empire, Property company up for sale Rolls poised for Boeing 747 order, Clean-engine contract worth 14bn Turmoil in the cinema boardroom, Odeon directors head for exit |
INDEPENDENT Corus accuses utilities of electricity rebate scam Vodafone, mmO2, Orange Hello? Is anybody out there listening? British Energy Energy minister to bat for BNFL in Japan |
The Week Ahead: Glaxo update will be easy to swallow HSBC From the ivory tower to Bangalore, the world's local bank listens no more |
SCOTLAND ON SUNDAY Barclays Concern over corporate credit quality Allied Domecq Whisky giants in high spirits as sales healthy Wolfson's full debut to shed light on strength of electronics sector Online Travel All-Hotels to shed jobs in cost-cutting drive |
Cheer for AWG investors with 150m property sale Caledonia Investments Cayzer saga must not drag on Staff pour 3m into coffers of Martin Currie BA faces extra 100m pension bill a year |
INVESTORS CHRONICLE Tips: Buy Imperial Tobacco (IMT) at 976p - John Laing (LNGO) at 164p - Tellings Golden Miller (TGM) at 105p - Tex (TXH) at 135p - Stream Group (SEA) at 16p. Sell Computacenter (CCC) at 437p.Tip Updates: Buy Smith & Nephew (SN) and Cookson (CKSN). Hold Fairplace Consulting (FCO). Air Music and Media (AMU) and ITE (ITE) are good value.Company Results: Buy Bellway (BWY). |
|
SHARES MAGAZINE Plays of the Week: Buy Henlys (HNL) at 90p - Zoo Digital (ZOO) at 9.1p - Pennant International (PEN) at 16p.Tip Updates: Buy Arena Leisure (ARE) and Inveresk (IVS). Sell Brit Insurance (BRE), Gaming Plays to Gamble On, Speculative Buy London Clubs (LCI), Buy Paddy Power (PAP). Hold Rank Group (RNK) and William Hill (WMH), Reduce Stanley Leisure (SLY). Neutral Wembley (WMY). |
![]() |
|
|
|
![]() |